ARCHIVES

Philadelphia Group Begins BMT Trial for Breast Cancer

This article is from The Cancer Letter archive.

Vol. 17 No. 14 | April 5, 1991

Download PDF Visit The Full Archive

Related Articles

Ungerleider To Leave NCI For Theradex Corp.

November 24, 2000

NIGMS Forms Bioinformatics, Computational Bio Center.

May 25, 2001

In Brief: DeVita, FDA Chief Help Kill California Bill Legalizing Laetrile Wit committee Testimony

August 26, 1977

Cancer Centers Win Majority Of Grants In Recent NCI RFAs, Klausner Tells AACI.

October 6, 2000

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

September 7, 1990